Insider plans sale of 7,000 shares of PEGA stock

Rhea-AI Filing Summary

A Form 144 notice reports that an insider plans to sell 7,000 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate aggregate market value of 302155.00 as of the filing. The securities relate to an issuer with 169,043,716 shares outstanding at the time of the notice.

The 7,000 shares to be sold were acquired on 10/24/2025 by exercising stock options under a registered plan, paid for in cash on the same date. The filing also discloses that the same person sold 4,000 common shares on 12/08/2025 for gross proceeds of 240756.00 over the prior three months.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7000	302155.00	169043716	02/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/24/2025	Exercise of options under a registered plan	Issuer			7000	10/24/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
RIFAT KERIM AKGONUL 225 Wyman Street Waltham MA 02451	COMMON	12/08/2025	4000	240756.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for PEGA report?

The Form 144 reports a planned sale of 7,000 common shares. These shares are to be sold on NASDAQ through Morgan Stanley Smith Barney LLC, reflecting an aggregate market value of 302,155.00 and were acquired by exercising options under a registered plan.

How many PEGA shares are planned to be sold under this Form 144?

The filing covers a planned sale of 7,000 common shares. These shares were obtained on 10/24/2025 via an option exercise under a registered plan, paid in cash, and are scheduled for sale on NASDAQ through Morgan Stanley Smith Barney LLC.

What is the reported market value of the PEGA shares to be sold?

The 7,000 shares have an aggregate market value of 302,155.00. This value is based on the market at the time of the notice and relates to common stock to be sold on NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services.

How many PEGA shares were outstanding at the time of this notice?

The issuer had 169,043,716 shares outstanding. This figure provides context for the 7,000-share planned sale reported on Form 144 and reflects the total common shares outstanding when the notice was prepared for NASDAQ trading.

What prior PEGA share sales by this person are disclosed in the Form 144?

The filing discloses a prior sale of 4,000 common shares. That transaction occurred on 12/08/2025 and generated gross proceeds of 240,756.00, representing securities of the same issuer sold within the previous three months.

How were the PEGA shares in this Form 144 acquired by the insider?

The 7,000 shares were acquired through option exercise under a registered plan. The acquisition occurred on 10/24/2025, with the person paying cash on that date to exercise options granted by the issuer, before planning the subsequent sale.